DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer

Nucleic Acids Research

Volumn 36, Issue 9, 2008, Pages

  Wang, Gary P ^a   Garrigue, Alexandrine ^b   Ciuffi, Angela ^a   Ronen, Keshet ^a   Leipzig, Jeremy ^a   Berry, Charles ^c   Lagresle Peyrou, Chantal ^b,c   Benjelloun, Fatine ^b,d   Hacein Bey Abina, Salima ^b,e   Fischer, Alain ^b,d   Cavazzana Calvo, Marina ^b,d,e   Bushman, Frederic D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMIS PROTEIN; GAMMA RETROVIRUS VECTOR; GENE THERAPY AGENT; GENOMIC DNA; LENTIVIRUS VECTOR; ONCOPROTEIN; RAG1 PROTEIN; RESTRICTION ENDONUCLEASE; RETROVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA BARCODING; DNA INTEGRATION; DRUG SURVEILLANCE PROGRAM; GENE FREQUENCY; GENE ISOLATION; GENE LOCATION; GENE SEQUENCE; GENE TRANSFER; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; HUMAN; IMMUNE DEFICIENCY; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROVIRUS; PYROSEQUENCING; TISSUE DISTRIBUTION; UNINDEXED SEQUENCE; VIRAL GENE DELIVERY SYSTEM; ANIMAL; CELL PROLIFERATION; DISEASE MODEL; DNA SEQUENCE; EVALUATION; GENE THERAPY; GENE VECTOR; GENETICS; LENTIVIRINAE; METHODOLOGY; PROTO ONCOGENE; TUMOR SUPPRESSOR GENE;

MUS;

ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DNA RESTRICTION ENZYMES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; LENTIVIRUS; LYMPHOPROLIFERATIVE DISORDERS; MICE; PROTO-ONCOGENES; SEQUENCE ANALYSIS, DNA;

EID: 44349158394     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn125     Document Type: Article

References (40)

1. Cavazzana-Calvo,M., Hacein-Bey,S., de Saint Basile,G., Gross,F., Yvon,E., Nusbaum,P., Selz,F., Hue,C., Certain,S., Casanova,J.L. et al. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-XI disease. Science, 288, 669-672.
2. Aiuti,A., Slavin,S., Aker,M., Ficara,F., Deola,S., Mortellaro,A., Morecki,S., Andolfi,G., Tabucchi,A., Carlucci,F. et al. (2002) Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative, conditioning. Science, 296, 2410-2413.
3. Ott,M.G., Schmidt,M., Schwarzwaelder,K., Stein,S., Siler,U., Koehl,U., Glimm,H., Kuhlcke,K., Schilz,A., Kunkel,H. et al. (2006) Correction ot X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med., 12, 401-409.
4. Hacein-Bey-Abina,S., von Kalle,C., Scmidt,M., Le Deist,F., Wulffraat,N., McIntyre,E., Radford,I., Villeval,J.L., Fraser,C.C., Cavazzana-Calvo,M. et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med., 348, 255-256.
5. Hacein-Bey-Abina,S., von Kalle,C., Schmidt,M., McCormack,M.P., Wulffraat,N., Leboulch,P., Lim,A., Osborne,C.S., Pawliuk,R., Morillon,E. et al. (2003) LM02-associated clonal T cell proliferation in two patients after gene theraphy for SCID-X1. Science, 302, 400-401.
6. Schwarz,K., Gauss,G.H., Ludwig,L., Pannicke, U., Liz,Z., Lindner,D., Friedrich,W., Seger,R.A., Hansen-Hagge,T.E., Desiderios,S. et al. (1996) RAG mutations in human B cell-negative SCID. Science, 274, 97-99.
7. Corneo,B., Moshous,D., Gungor,T., Wulffraat,N., Philippet,P., Le Deist,F.L., Fischer,A. and de Villartay,J.P. (2001) Identical mutatiom in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B-severe combined immune deficiency or omenn syndrome. Blood, 97, 2772-2776.
8. Moshous,D., Callebaut,I., de Chasseval,R., Corneo,B., Cavazzana-Calvo,M., Le Deist,F., Tezcan,I. Sanal,O., Bertrand,Y., Philippe,N. et al. (2001) Artemis, a novel DNA double-strand break repair/V(D)J combination protein, is mutated in human severe combined immune deficiency. Cell, 105, 177-186.
9. Mostoslavsky,G., Fabian,A.J., Rooney,S., Alt,F.W. and Mulligan,R.C. 2006 Complete correction of murine artemis immunodeficiency by lentiviral vector-mediated gene transfer. Proc. Natl Acad. Sci. USA, 103 16406-16411.
10. Benjelloun,F., Garrigue,A., Demerens C., Malassis-Séris,M., Stockholm,D., Blondeau,J., Rivière,J., Lim,A., David,S.P., Dutrillaux,R.S. et al. Stable and functional lymphoid reconstitution in artermis-deficient mice following ex-vivo gene transfer with lentiviral vector. Mol. Ther., in press
11. Lagresle-Peyrou,C, Yates,F., Malassis-Seris,M., Hue,C., Morillon,E., Garrigue,A., Liu,A., Hajdari,P., Stockholm,D., Danos,O. et al. (2006) Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene theraphy: A balance between efficiency and toxicity. Blood, 107, 63-72.
12. Rooney,S., Sekiguchi.J., Zhu,C., Cheng.H.L., Manis,J., Whitlow,S., DeVido,J., Foy,D., Chaudhuri,J., Lombard,D. et al. (2002) Leaky scid phenotype associated with defective V(D)J coding end processing in artemis-deficient mice. Mol. Cell, 10, 1379-1390.
13. Margulies,M., Egholm,M., Altman,W.E., Attiya,S., Bader,J.S., Bemben,L.A., Berka,J., Braverman,M.S., Chen,Y.J., Chen,Z. et al. (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature, 437, 376-380.
14. Hoffmann,C., Minkah,N., Leipzig,J., Wang,G., Arens,M.Q., Tebas,P. and Bushman,F.D. (2007) DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations. Nucleic Acids Res., 35, e91.
15. Binladen,J., Gilbert,M.T., Bollback,J.P., Panitz,F., Bendixen,C., Nielsen,R. and Willerslev,E. (2007) The use of coded PCR primers enables high-throughput sequencing of multiple homolog amplification products by 454 parallel sequencing. PLoS ONE, 2, e197.
16. Shoemaker,D.D., Lashkari,D.A., Morris,D., Mittmann,M. and Davis,R.W. (1996) Quantitative phenotypic analysis of yeast deletion mutants using a highly parallel molecular bar-coding strategy. Nat. Genet., 14, 450-456.
17. Ciuffi,A., Llano,M., Poeschla,E., Hoffmann,C., Leipzig,J., Shinn,P., Ecker,J.R. and Bushman,F.D. (2005) A role for LEDGF/p75) in targeting HIV DNA integration. Nat. Med., 11, 1287-1289.
18. Wang,G.P., Ciuffi,A., Leipzig,J., Berry,C.C. and Bushman,F.D. (2007) HIV integration site selection: Analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res., 17, 1186-1194.
19. Mitchell,R., Beitzel,B., Schroder,A., Shinn,P., Chen,H., Berry,C., Ecker,J.R. and Bushman,F.D. (2004) Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol., 2, E234.
20. Wu,X., Li,Y., Crise,B. and Burgess,S.M. (2003) Transcription start regions in the human genome are favored for MLV integration. Science 300. 1749-1751.
21. Schmidt,M., Zickler,P., Hoffmann,G., Haas,S., Wissler,M., Muessig,A., Tisdale,J.F., Kuramoto,K., Andrews,R.G., Wu,T. et al. (2002) Polyclonal long-term repopulating stem cell clones in a primate model. Blood, 100, 2737-2743.
22. Huret,J.L., Minor,S.L., Dorkeld,F., Dessen,P. and Bernheim,A. (2000) Atlas of genetics and cytogenetics in oncology and haematology, an interactive database. Nucleic Acids Res., 28, 349- 351.
23. Akagi,K., Suzuki,T., Stephens,R.M., Jenkins,N.A. and Copeland,N.G. (2004) RTCGD: Retroviral tagged cancer gene database. Nucleic Acids Res., 32, D523-527.
24. Futreal,P.A., Coin,L., Marshall,M., Down,T., Hubbard,T., Wooster,R., Rahman,N. and Stratton,M.R. (2004) A census of human cancer genes. Nat. Rev. Cancer., 4, 177-183.
25. Sjoblom,T.D., Mandelker,D., Leary,R.J., Ptak,J., Silliman,N. et al. (2006) The consensus coding sequences ot human breast and colorectal cancers. Science, 314, 268-274.
26. BerryC.C., Hannenhalli,S., Leipzig,J. and Bushman,F.D. (2006) Selection of target sites for mobile DNA integration in the human genome. 2, e157.
27. Sirven,A., Ravet,E., Charneau,P., Zennou,V., Coulombel,L., Guetard,D., Pflumio,F. and Dubart-Kupperschmitt,A. (2001) Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol. Ther., 3, 438-448.
28. Holyoake,T.L., Freshney,M.G., Samuel,K., Ansell,J., Watson,G.E., Wright,E.G., Graham,G.J. and Pragnell,I.B. (2001) In vivo expansion of the endogenous, B-cell compartment stimulated by radiation and seriai bone marrow transplantation induces B-cell leukaemia in mice. Br. J. Haematol., 114, 49-56.
29. Schroder,A., Shinn,P., Chen,H., Berry,C., Ecker,J.R. and Bushman,F.D. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110, 521-529.
30. Barr,S.D., Ciuffi,A., Leipzig.J., Shinn,P., Ecker,J.R. and Bushman,F.D. (2006) HIV integration site selection: Targeting in macrophages and the effects of different routes of viral entry.
31. Barr,S.D., Leipzig,J., Shinn,P., Ecker,J.R. and Bushman,F.D. (2005) Integration targeting by avian sarcama-leukosis virus and human immunodeficiency virus in the chicken genome. J. Virol., 79, 12035-12044.
32. Ciuffi,A., Mitchell,R.S., Hoffman,C., Leipzig,J., Shinn,P., Ecker,J.R. and Bushman,F.D. (2006) Integration site selection by HIV-based vectors: targeting in dividing and nondividing IMR-90 lung fibroblasts. Mol. Ther., 13, 366-373.
33. Lewinski,M., Bisgrove,D., Shinn,P., Chen,H., Verdin,E., Berry,C.C., Ecker,J.R. and Bushman,F.D. (2005) Genome-wide analysis of chromosomal features repressing HIV transcription. J. Virol., 79, 6610-6619.
34. Aiuti,A., Cassani,B., Andolfi,G., Mirolo,M., Biasco,L., Recchia,A., Urbinati,F., Valacca,C., Scaramuzza,S., Aker,M. et al. (2007) Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene theraphy. J. Clin. Invest., 117, 233-2240.
35. Lewinski,M., Yamashita,M., Emerman,M., Ciuffi,A., Marshall,H., Crawford,G., Collins,F., Shinn,P., Leipzig,J., Hannenhalli,S. et al. (2006) Retroviral DNA integration: Viral and cellular determinants of target site selection. PLOS Pathogens, 2, e60.
36. De Palma,M., Montini,E., Santoni de Sio,F.R., Benedicenti,F., Gentile,A., Medico,E. and Naldini,L. (2005) Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoetic cells. Blood, 105, 2307-2315.
37. Turlure,F., Maertens,G., Rahman,S., Cherepanov,P. and Engelman,A. (2006) A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo. Nucleic Acids Res., 34, 1653-1675.
38. Cattoglio,C., Facchini,G., Sartori,D., Antonelli,A., Miccio,A., Cassani,B., Scmidt,M., von Kalle,C., Howe,S., Thrasher,A.J. et al. (2007) Hot spots of retroviral integration in human CD34+hematopoietic cells. Blood, 110, 1770-1778.
39. Hacein-Bey-Abina,S., Garrigue,A., Wang,G.P. Soulier,J., Lim,A., Morillon,E., Clappier,E., Caccavelli,L., Delabesse,E., Beldjord,K., et al. (2008) Oncogenesis by insertional activation in four patients after retrovirus-mediated gene theraphy of SCID-X1, submitted for publication.
40. Schmidt,M., Hoffmann,G., Wissler,M., Lemke,N., Mubig,A., Glimm,H., Williams,D.A., Ragg,S., Hesemann,C.-. and von Kalle,C. (2001) Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. Hum. Gene Ther., 12, 743-749.